Patients who receive a heart valve replacement are well-known to be at a high risk for stroke, blood clots and deep vein ...

Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots for patients after heart valve replacement surgery, according to preliminary ...

A large-scale clinical trial found that intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) analog medication, during heart surgeries involving bypass did not significantly reduce the ...

More young people are experiencing strokes and researchers at Cleveland Clinic have published new findings exploring the ...

CNW/ - Ginkgo Health Inc., a pioneering technology startup aiming to reduce the global healthcare burden, is set to launch ...

AFib is the most common type of irregular heart rhythm in the U.S., and blood thinners, also known as anti-clotting ...

The two strategies, used to reduce renal, brain, and heart injury after surgery, were ineffective, but the story isn’t done.

The Cottage Heart & Vascular Center’s structural heart team at Santa Barbara Cottage Hospital (SBCH) recently performed their ...

New research has found that women have a higher risk of developing cardiovascular issues, including stroke and heart failure, ...

That Thursday, for the first time, the European Medicines Agency (EMA) approved a drug that targets the cause — not just the ...

Are you or a loved one struggling with swallowing? Swallowing difficulties, medically known as dysphagia, are becoming ...

An AI tool called Muse aims to optimize clinical trial patient recruitment and accelerate the development of new therapies.